Aktis Oncology Shares Surge Over 5% on First Trading Day
With the first biotech IPO of the year, Aktis Oncology blew past expectations, with shares jumping on the first day of trading.LATEST IPOS AND DIRECT LISTINGS:Aktis Oncologyopened on January 9 at $27. The clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations priced its upsized initial public offering of 17.65M shares of its common stock at a price to the public of $18.00 per share. The deal priced at the high-end of the $16.00-$18.00 range.Buda Juiceopened on January 8 at $12. The company priced its initial public offering of 2,666,667 shares of its common stock at the public offering price of $7.50 per share. The deal priced at the low end of its $7.50-$9.00 range. Buda Juice intends to use the net proceeds from the offering to develop and build production plants in South Carolina and Arizona/Nevada, expand capacity in its Dallas production plant, support in-store marketing and provide working capital for its expansion of its freshly crafted juices, lemonades, and wellness shots to grocery retailers.RECENT SPAC IPOS:Lafayette Digital Acquisition Iopened on January 9 at $10.01. The blank check company had priced its initial public offering of 25M units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-fourth of one redeemable warrant. Each whole warrant, which becomes exercisable 30 days after the completion of the company's initial business combination, will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share, subject to adjustments.Bleichroeder Acquisition IIopened on Jnauary 8 at $10.03. The blank check company may pursue an acquisition opportunity in any industry, sector or geographic region. The company's primary focus, however, will be on North American and European businesses in disruptive growth sectors, which may include companies within sectors that are being transformed via technology adoption.Soren Acquisitionopened on January 7 at $10. The blank check company may pursue an acquisition opportunity in any business or industry or at any stage of its corporate evolution, but is focused on completing a business combination with "an attractive target business within the healthcare industry".Black Spade Acquisition IIIopened on January 6 at $9.97. The special purpose acquisition company is sponsored by an affiliate of Black Spade Capital Limited.PERFORMANCE:Prices as of 11 am ET on Monday, January 12 -Aktis Oncology – up over 5% at $23.53;Buda Juice – up almost 2% at $8.31.RECENT IPOS TO WATCH:Medlineand Andersen Groupare already seeing coverage roll out, while Starfighters Spaceis among stocks that could see new coverage this week as the quiet periods for banks that underwrote the companies' IPOs expire.UPCOMING IPOS:Upcoming IPO and direct listings expected include PicS N.V., Grayscale, Klook, Speed Group, and Lendbuzz.Clickto see upcoming IPO calendar on TipRanks.PicS N.V.filed for an initial public offering of Class A common shares, which it intends to apply to list on the Nasdaq Global Select Market under the symbol "PICS." The company said it will not seek a listing for its Class B common shares on Nasdaq or on any other exchange. The filing stated, "PicPay Netherlands, the company whose Class A common shares are being offered in this prospectus, was incorporated on December 27, 2023, as a private limited liability company under Dutch law, with its corporate seat in Amsterdam, the Netherlands, with the name 'Picpay Holdings Netherlands B.V.' Prior to the closing of this offering, the issuer will be converted into a public limited liability company under Dutch law with the name 'PicS N.V.'... At PicPay, we believe financial services should be mobile, frictionless, and instantaneous. Our mission is to empower consumers and businesses across Brazil with innovative solutions to redefine the way people manage their traditional daily finances. We break down the barriers to traditional financial services and are driven by a vision of a future where financial services are accessible for all. We are committed to simplifying financial transactions, fostering economic inclusion and providing the tools and resources for people to achieve their financial goals."GrayscaleInvestments filed a prospectus for an initial public offering on the New York Stock Exchange under the ticker symbol "GRAY." Grayscale says it is the largest digital asset-focused investment platform in the world, with $35B in assets under management as of September 30. "Our mission is to make digital asset investing simple and open to every investor. Founded in 2013, we have pioneered regulated access to the digital asset class. Our platform spans the full spectrum of institutional-grade solutions, providing investors with the broadest and most diverse suite of digital asset-focused investment products in the United States based on number of products," the company added.Klook Technology, which identifies itself as "the largest pan-regional experiences platform in Asia-Pacific" by gross transaction volume in 2024, announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of American Depositary Shares representing its ordinary shares. The company has applied to list the ADSs on the New York Stock Exchange under the ticker symbol "KLK". The number of ADSs to be offered and the price range for the proposed offering have not yet been determined.Speed Groupfiled a prospectus for 2.5M share initial public offering. It expects the IPO price to be in the range of $4.00 to $5.00 per. The company's operating subsidiary, Speed Logistics, is an e-commerce logistics provider providing end-to-end logistics solution in Hong Kong, Europe and North America. The services include warehousing, customs clearance, air transportation, and final delivery from the European airports. For the years ended June 30, 2024 and 2025, Speed's revenues were $17.9M and $22.64M, respectively.Lendbuzz Inc.is offering an undetermined number of shares of its common stock and the selling stockholders identified in this prospectus are offering additional shares of common stock, according to an initial public offering prospectus filed with the SEC. The company has applied to list its common stock on the Nasdaq Global Select Market under the symbol "LBZZ." The prospectus states: "Our mission is to offer fair access to credit for underserved populations. We are a financial technology company that utilizes artificial intelligence, or AI, and machine learning algorithms to better assess consumer credit risk and expand access to credit. We seamlessly process large sets of data through advanced computational approaches to more accurately predict a consumer's creditworthiness. Our business benefits both consumers through expanded access to credit, and auto dealerships via increased vehicle sales."OTHER IPO NEWS:Construction equipment rental firm EquipmentShare.com, which filed publicly for a listing on December 9, may begin formal marketing for its initial public offering as soon as next week and could raise about $1B, a person familiar with the matter told Bloomberg's Bailey Lipschultz and Anthony Hughes. Motive Technologies, which makes artificial intelligence-enabled fleet management software and filed its IPO paperwork publicly on December 23, may also begin formal marketing next week as it seeks to raise around $600M, the report noted that a person with knowledge of the deal said."Opening Day" is The Fly's recurring series of stories on the latest initial public offerings, their performance, and upcoming IPOs.
Trade with 70% Backtested Accuracy
Analyst Views on MDLN
About MDLN
About the author

- New Distribution Center: Medline plans to construct a new 1.2 million sq. ft. distribution center in Midlothian, Texas, expected to be fully operational by Q2 2027, marking the company's first new DC in 2026 and reflecting its ongoing growth trajectory post-IPO.
- Market Expansion Strategy: This distribution center will complement the existing Wilmer location in the Dallas-Fort Worth market, aimed at serving the expanding customer base in the region, thereby strengthening Medline's market position in the healthcare supply chain.
- Technological Investment Upgrade: The new center will incorporate advanced technologies used in Medline's other large distribution centers, including the AutoStore storage and retrieval system, which is expected to enhance operational efficiency and optimize inventory management, improving customer service capabilities.
- Customer Service Commitment: Medline's distribution network enables next-day delivery to 95% of its U.S. customers, and with over 26 million square feet of warehouse space and 80 days of inventory, the company demonstrates a strong commitment to meeting evolving customer needs through continuous investment.
- New Distribution Center: Medline plans to construct a new 1.2 million sq. ft. distribution center in Midlothian, Texas, expected to be fully operational by Q2 2027, marking the company's first new DC in 2026 and reflecting its ongoing growth trajectory post-IPO.
- Network Expansion Strategy: This center will complement the existing Wilmer location in the Dallas-Fort Worth market, aimed at addressing the expanding customer base in the region, thereby enhancing Medline's market position in the healthcare supply chain.
- Technological Innovation: The new facility will incorporate advanced technologies similar to those used in Medline's other large distribution centers, including the AutoStore storage and retrieval system, which is expected to improve operational efficiency and optimize inventory management for faster customer response.
- Enhanced Customer Service: Medline's distribution network enables next-day delivery to 95% of its U.S. customers, showcasing its commitment and capability to meet customer needs, further solidifying its leadership position in the medical product supply chain.
- Successful Secondary Offering: Medline Inc. has completed a secondary offering of 86.25 million shares of Class A common stock at a public price of $41.00 per share, indicating sustained market demand despite the company not participating directly in the sale.
- Key Shareholder Participation: The offering involved selling stockholders affiliated with Blackstone, Carlyle Group, and Hellman & Friedman, suggesting these investors maintain an optimistic outlook on Medline's long-term prospects, potentially boosting market confidence.
- Strong Underwriter Lineup: Top investment banks including Goldman Sachs, Morgan Stanley, and BofA Securities acted as global coordinators, reflecting market recognition of Medline and laying a foundation for future financing activities.
- Compliance Statement: The offering adheres to SEC registration statements, ensuring compliance and reducing legal risks, which further enhances investor trust in Medline.
- Annual Awards Ceremony: Medline awarded its 2025 Distribution Center of the Year and SAFE Awards to top-performing facilities in the U.S., highlighting the company's commitment to operational excellence across safety, service, and quality metrics.
- Award Distribution: Rialto, California, and Katy, Texas, received the Distribution Center of the Year and SAFE Awards respectively, while Richmond, Virginia, achieved the rare distinction of winning both awards, showcasing its outstanding safety and service performance.
- Supply Chain Efficiency: Medline's network of 45 distribution centers enables next-day delivery to 95% of U.S. customers, reflecting the company's effective management of healthcare supply chains and the dedication of its team members.
- Safety Culture Development: The Richmond center's team emphasizes that safety is not just a program but a core part of their culture, ensuring employees work in a safe environment, which enhances overall service quality and employee satisfaction.
- Distribution Center Awards: Medline has awarded its 2025 Distribution Center of the Year awards to facilities excelling in safety, service, quality, cost, and personnel, reflecting the company's ongoing commitment to operational excellence.
- Safety Awareness Recognition: The 2025 SAFE Award recipients include Katy, Texas; Mebane, North Carolina; Richmond, Virginia; and Lincolnton, North Carolina, highlighting Medline's outstanding performance in safety management.
- Next-Day Delivery Capability: Medline achieves a 95% next-day delivery rate for U.S. customers through its network of 45 distribution centers, showcasing its robust supply chain capabilities and the dedication of its team to ensure timely delivery of medical products.
- Cultural Commitment: The Richmond distribution center's dual award recognition underscores the team's commitment to safety culture and mutual support, enhancing employee satisfaction and safety awareness in the workplace.
- Offering Size: Medline announced a secondary public offering of 75 million shares priced at $41 each, valuing the transaction at approximately $3.08 billion, providing liquidity for existing investors while the company itself is not directly involved.
- Key Investors: The shares are being sold by existing investors linked to Blackstone, The Carlyle Group, Hellman & Friedman, and a subsidiary of Abu Dhabi Investment Authority, indicating strong confidence from these institutional players in the market.
- Underwriter Option: The underwriters have a 30-day option to purchase up to an additional 11.25 million shares, which could further influence market supply and demand dynamics, potentially increasing investor participation.
- Market Reaction: Following the announcement, Medline's stock dipped slightly to $42.75 in pre-market trading on Thursday, reflecting a cautious market sentiment regarding the offering, which may impact short-term stock performance.









